<DOC>
	<DOCNO>NCT01028976</DOCNO>
	<brief_summary>The purpose study determine whether Vitamin C ( 1000 mg/day ) reduce marker inflammation , especially C-reactive protein ( CRP ) , obese person baseline CRP great 1 mg/dl .</brief_summary>
	<brief_title>Obesity , Inflammation Oxidative Stress</brief_title>
	<detailed_description>The long-term objective project identify nutritional factor reduce inflammatory component obesity . Therapies minimize obesity-related comorbidities need , target inflammation may help slow progression obesity towards cardiovascular disease insulin resistance . Adipose tissue source inflammatory cytokine , obesity view chronic , low-grade inflammatory state . Inflammation contributor chronic disease associate obesity . C-reactive protein ( CRP ) key marker inflammation , downstream marker provide functional integration upstream cytokine activation associate inflammation . We previously show vitamin C , vitamin E , reduce CRP active passive smoker nonsmoker . The reduction see primarily person CRP ≥1.0 mg/L , CDC threshold elevate cardiovascular disease risk . We also find 75 % obese nonsmoker CRP ≥1.0 mg/L . The important observation reduction elevate CRP vitamin C need confirm rigorous study adequate sample size , permit justifiable conclusion potential usefulness agent reduce inflammation obese . We conduct placebo-controlled , randomized trial 552 healthy obese individual moderate CRP elevation ( CRP ≥1.0 mg/L ) . Participants randomize either 1000 mg/day vitamin C placebo period 2 month . We also characterize pathway effect take place measure cytokine oxidative stress . This project important previous finding confirm population , could offer low-cost alternative use statin reduce inflammation person without risk factor .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>BMI ≥ 30 hsCRP ≥ 1 mg/L Age 18+ Member Kaiser Permanente Health Plan Northern California Smoker Unwilling discontinue vitamin supplement study duration Unwilling/unable use acetaminophen place OTC antiinflammatory medication Use certain medication History certain medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>randomize control trial</keyword>
	<keyword>primary prevention</keyword>
	<keyword>Vitamin C</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>C-reactive protein</keyword>
	<keyword>inflammation</keyword>
	<keyword>anti-inflammatory agent</keyword>
	<keyword>obesity</keyword>
</DOC>